122 related articles for article (PubMed ID: 2836425)
1. A test for the relative potency of herpes simplex virus vaccines based upon the female guinea-pig model of HSV 2 genital infection.
Phillpotts RJ; Welch MJ; Ridgeway PH; Walkland AC; Melling J
J Biol Stand; 1988 Apr; 16(2):109-18. PubMed ID: 2836425
[TBL] [Abstract][Full Text] [Related]
2. Herpes simplex virus genital infection of the female guinea pig as a model for the evaluation of an experimental vaccine.
Thornton B; Baskerville A; Bailey NE; Melling JM; Hambleton P
Vaccine; 1984 Jun; 2(2):141-8. PubMed ID: 6099646
[TBL] [Abstract][Full Text] [Related]
3. Vaccination with recombinant herpes simplex virus glycoproteins: protection against initial and recurrent genital herpes.
Stanberry LR; Bernstein DI; Burke RL; Pachl C; Myers MG
J Infect Dis; 1987 May; 155(5):914-20. PubMed ID: 3031173
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of recombinant glycoprotein D subunit vaccines on the development of primary, recurrent, and latent genital infections with herpes simplex virus type 2 in guinea pigs.
Berman PW; Vogt PE; Gregory T; Lasky LA; Kern ER
J Infect Dis; 1988 May; 157(5):897-902. PubMed ID: 2834467
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of HSV-1 ISCOM vaccine in the guinea-pig model of HSV-2 infection.
Erturk M; Phillpotts RJ; Welch MJ; Jennings R
Vaccine; 1991 Oct; 9(10):728-34. PubMed ID: 1661978
[TBL] [Abstract][Full Text] [Related]
6. A Dual-Modality Herpes Simplex Virus 2 Vaccine for Preventing Genital Herpes by Using Glycoprotein C and D Subunit Antigens To Induce Potent Antibody Responses and Adenovirus Vectors Containing Capsid and Tegument Proteins as T Cell Immunogens.
Awasthi S; Mahairas GG; Shaw CE; Huang ML; Koelle DM; Posavad C; Corey L; Friedman HM
J Virol; 2015 Aug; 89(16):8497-509. PubMed ID: 26041292
[TBL] [Abstract][Full Text] [Related]
7. The HSV-1 live attenuated VC2 vaccine provides protection against HSV-2 genital infection in the guinea pig model of genital herpes.
Bernstein DI; Pullum DA; Cardin RD; Bravo FJ; Dixon DA; Kousoulas KG
Vaccine; 2019 Jan; 37(1):61-68. PubMed ID: 30471955
[TBL] [Abstract][Full Text] [Related]
8. Use of herpes simplex virus (HSV) type 1 ISCOMS 703 vaccine for prophylactic and therapeutic treatment of primary and recurrent HSV-2 infection in guinea pigs.
Simms JR; Heath AW; Jennings R
J Infect Dis; 2000 Apr; 181(4):1240-8. PubMed ID: 10762560
[TBL] [Abstract][Full Text] [Related]
9. Immunity induced by DNA immunization with herpes simplex virus type 2 glycoproteins B and C.
Mester JC; Twomey TA; Tepe ET; Bernstein DI
Vaccine; 1999 Dec; 18(9-10):875-83. PubMed ID: 10580201
[TBL] [Abstract][Full Text] [Related]
10. Effects of DNA immunization formulated with bupivacaine in murine and guinea pig models of genital herpes simplex virus infection.
Bernstein DI; Tepe ER; Mester JC; Arnold RL; Stanberry LR; Higgins T
Vaccine; 1999 Apr; 17(15-16):1964-9. PubMed ID: 10217595
[TBL] [Abstract][Full Text] [Related]
11. Recurrent genital herpes simplex virus infection in guinea pigs.
Stanberry LR; Kern ER; Richards JT; Overall JC
Intervirology; 1985; 24(4):226-31. PubMed ID: 3000982
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of the Herpes Simplex Virus 2 (HSV-2) Glycoprotein D/AS04 Vaccine against Genital HSV-2 and HSV-1 Infection and Disease in the Cotton Rat Sigmodon hispidus Model.
Boukhvalova M; McKay J; Mbaye A; Sanford-Crane H; Blanco JC; Huber A; Herold BC
J Virol; 2015 Oct; 89(19):9825-40. PubMed ID: 26178984
[TBL] [Abstract][Full Text] [Related]
13. Protection and serum antibody responses in guinea-pigs and mice immunized with HSV-1 antigen preparations obtained using different detergents.
Ertürk M; Welch MJ; Phillpotts RJ; Jennings R
Vaccine; 1989 Oct; 7(5):431-6. PubMed ID: 2554607
[TBL] [Abstract][Full Text] [Related]
14. Antibody response to the herpes simplex virus type 2 AG-4 antigen in guinea pigs with genital herpes infections.
Maragos C; Miller A; May JT
Aust J Exp Biol Med Sci; 1986 Feb; 64 ( Pt 1)():89-95. PubMed ID: 3008691
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of herpes simplex virus vaccines in animals: the guinea pig vaginal model.
Stanberry LR
Rev Infect Dis; 1991; 13 Suppl 11():S920-3. PubMed ID: 1664129
[TBL] [Abstract][Full Text] [Related]
16. Vaccine induced HSV 1 antibodies fail to correlate with protection against HSV 2 in guinea pigs.
Welch MJ; Ridgeway PH; Phillpotts RJ
FEMS Microbiol Immunol; 1988 Dec; 1(3):157-62. PubMed ID: 2856207
[TBL] [Abstract][Full Text] [Related]
17. Antibody response, recurrence patterns and subsequent herpes simplex virus type 2 (HSV-2) re-infection following initial HSV-2 infection of guinea-pigs: effects of acyclovir.
Bernstein DI; Stanberry LR; Harrison CJ; Kappes JC; Myers MG
J Gen Virol; 1986 Aug; 67 ( Pt 8)():1601-12. PubMed ID: 3016155
[TBL] [Abstract][Full Text] [Related]
18. Immunogenicity, protective efficacy, and non-replicative status of the HSV-2 vaccine candidate HSV529 in mice and guinea pigs.
Bernard MC; Barban V; Pradezynski F; de Montfort A; Ryall R; Caillet C; Londono-Hayes P
PLoS One; 2015; 10(4):e0121518. PubMed ID: 25837802
[TBL] [Abstract][Full Text] [Related]
19. Comparison of different forms of herpes simplex replication-defective mutant viruses as vaccines in a mouse model of HSV-2 genital infection.
Da Costa XJ; Morrison LA; Knipe DM
Virology; 2001 Sep; 288(2):256-63. PubMed ID: 11601897
[TBL] [Abstract][Full Text] [Related]
20. Vaccination with a HSV-2 UL24 mutant induces a protective immune response in murine and guinea pig vaginal infection models.
Visalli RJ; Natuk RJ; Kowalski J; Guo M; Blakeney S; Gangolli S; Cooper D
Vaccine; 2014 Mar; 32(12):1398-406. PubMed ID: 24462481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]